Tag Archives: Non Hodgkins Lymphoma
Alfacell Achieves Full Patient Enrollment Milestone for the ONCONASE Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
Press Release from Alfacell Corporation February 27, 2006 BLOOMFIELD, N.J., Feb. 27 /PRNewswire-FirstCall/ — Alfacell Corporation (Nasdaq: ACEL – News) today announced that the full enrollment target of 316 patients has been reached for the international, confirmatory Phase IIIb registration trial evaluating ONCONASE® (ranpirnase), the Company’s lead investigational drug candidate, as a treatment for unresectable [...]
Posted in Pharmaceutical News
Tagged Alfacell Corporation, Asbestos, BLOOMFIELD, Fast Track, Mesothelioma, NCI, Non Hodgkins Lymphoma, NSCLC, ONCONASE, Orphan Drug, Registration Study, UMM
Leave a comment
